logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Return

Group B Streptococcus disease during infancy and risk of subsequent neurodevelopmental impairments in young children: a population-based cohort study in Ontario, Canada

delete2025-07-02
delete0
PRE
AI
R
Romina Fakhraei
D
Deshayne B. Fell
D
Darine El‐Chaâr
N
Nisha Thampi
B
Beate Sander
K
Kevin A. Brown
N
Natasha S. Crowcroft
S
Shelly Bolotin
J
Jon Barrett
E
Elizabeth Darling
N
Nahuel Fittipaldi
T
Theresa Lamagni
A
Allison McGeer
M
Michelle Murti
M
Manish Sadarangani
K
Kevin L. Schwartz
A
Abdool S. Yasseen
M
Matthew Tunis
W
William Petrcich
K
Kumanan Wilson
DOI：10.1016/j.lana.2025.101170delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Group B Streptococcus (GBS) is a leading infectious cause of neonatal morbidity and mortality worldwide, yet data on longer-term outcomes in children remain limited. We aimed to assess the risk of neurodevelopmental impairments (NDIs) in GBS survivors and to explore effect modification by sex and prematurity.
Keywords:
Group B Streptococcus
Streptococcus agalactiae
Neurodevelopmental impairments
Effect modification
Sex differences
Prematurity

Journal

L
Lancet Regional Health and Americas
IF:
7.6
Papers:
1.2K
Citations:
3.5K

Organization

No organization information available